INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $259,117 | -17.4% | 8,195 | +6.6% | 0.00% | -100.0% |
| Q2 2023 | $313,557 | -39.4% | 7,689 | -16.7% | 0.00% | 0.0% |
| Q3 2022 | $517,000 | +48.6% | 9,236 | +37.3% | 0.00% | 0.0% |
| Q2 2022 | $348,000 | -17.5% | 6,725 | +88.6% | 0.00% | 0.0% |
| Q4 2021 | $422,000 | -76.6% | 3,565 | -73.5% | 0.00% | -75.0% |
| Q3 2021 | $1,807,000 | -20.8% | 13,470 | -4.4% | 0.00% | -20.0% |
| Q2 2021 | $2,281,000 | +2751.2% | 14,091 | +197.0% | 0.01% | – |
| Q3 2018 | $80,000 | -50.0% | 4,745 | -19.1% | 0.00% | -100.0% |
| Q2 2018 | $160,000 | +841.2% | 5,866 | +633.2% | 0.00% | – |
| Q1 2018 | $17,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |